FTSE 100 hits two-year high as GSK boosts


Unilever shares dropped 7.0% and were the worst performer on the index. A report said the company was in talks with banks for additional financing to make a potential sweetened offer.

LONDON: London's FTSE ended higher on Monday, aided by healthcare stocks as GlaxoSmithKline jumped after rejecting a 50-billion-pound buyout offer for its consumer arm from Unilever, while energy and mining stocks also provided support.

The blue-chip FTSE 100 index gained 0.9% to record its highest closing in nearly two years, with miner Glencore and energy majors BP and Royal Dutch Shell among the biggest boosts to the index.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

FTSE 100 , two-year high , GSK , Uniliver ,

   

Next In Business News

Oil falls on prospect of higher-for-longer US rates
Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
Wellness a top priority
InNature diversifies into the F&B industry
Tolerance for a cheaper yuan may be temporary
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
China’s push for greener aluminium hit by erratic rains, power cuts

Others Also Read